Catalytic antibodies: Generation, nature, and possible role as chemical warfare scavengers

Military Medicine

Volumn 161, Issue 1, 1996, Pages 7-10

  Amital, H ^a   Tur Kaspa, I ^b   Tashma, Z ^b   Hendler, I ^b   Shoenfeld, Y ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MEDICAL CORPS   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYTIC ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; CHEMICAL WARFARE; ENZYME ACTIVITY; HOST RESISTANCE;

EID: 9044234406     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/161.1.7     Document Type: Article

References (36)

1. Pollack SJ, Jacobs WJ, Schultz PG: Selective chemical catalysis by an antibody. Science 1986; 234: 1570-3.
2. Tramontano A, Janda KD, Lerner RA: Chemical reactivity of an antibody binding site elicited by mechanistic design of a synthetic antigen. Proc Natl Acad Sci USA 1986: 83: 6736-40.
3. Lerner RA, Benkovic SJ, Schultz PG: At the crossroad of chemistry and immunology: catalytic antibodies. Science 1991; 252. 658-67.
4. Davies DR, Padlan EA, Sheriffs. Antibody-antigen complexes. Annu Rev Biochem 1990; 59: 439-73.
5. Haynes MR, Stura EA, Hilvert D, et al Routes to catalysis, structure at a catalytic antibody and comparison with its natural counterpart. Science 1994: 263: 646-52.
6. Tramontano A, Janda KD, Lerner RA Catalytic antibodies Science 1986; 234: 1566-70.
7. Kohler E, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256 495-505.
8. Adler TR, Beall GN, Curd JG, et al: Studies of complement activation and IgG subclass restriction of anti-thyroglobulin. Clin Exp Immunol 1984; 56: 383-9.
9. Li L, Paul S, Tyutyulkova S, et al: Catalytic activity of anti-thyroglobulin antibodies. J Immunol 1995: 154: 3328-32.
10. Shuster AM, Gololobov GV, Kvashuk DA, et al: Anti-idiotypic and natural catalytically active antibodies Mol Biol (Mosk) 1991; 25: 593-602.
11. Pauling L: Chemical achievements and hope for the future. Am Sci 1948; 50: 50-8.
12. Jencks W: Catalysis in Chemistry and Enzymology, pp 288. New York, McGraw-Hill, 1969.
13. Jacobs J, Schultz PC, Sugasawara R, Powell M. Catalytic antibodies. J Am Chem Soc 1987, 109. 2174-6.
14. Green SB, Tawfik DS: Catalytic monoclonal antibodies: tailor-made, enzyme-like catalysts for chemical reactions. TIBITECH 1989: 7: 304-10.
15. Tawfik DS, Eshar Z, Green BS: Catalytic antibodies: a clinical assessment Molecular Biotechnology 1994; 1: 87-103.
16. Pollack SJ, Shultz PG. Antibody catalysis by transition state stabilization. Cold Spring Harb Symp Quant Biol 1987; 52. 97-104.
17. Pollack SJ, Nakayama GR, Shultz PG: Design of catalytic antibodies. Methods Enzymol 1989; 78: 551-8.
18. Iverson BL, Lerner RA. Sequence specific peptide cleavage catalyzed by an antibody. Science 1989; 243: 1184-8
19. Pollack SJ, Nakayama GR, Shultz PG: Introduction of nucleophiles and spectrophotometric probes into antibody combining sites. Science 1988; 242: 1038-40.
20. Lerner RA, Tramontano A. Catalytic antibodies. Sci Am 1988, 258 58-60.
21. Cochran AG, Sugasawara R, Shultz PG: Photosensitized cleavage of a thymine dimer by an antibody. J Am Chem Soc 1988; 110: 7888-90.
22. Dunn MA, Sidell FR: Progress in medical defense against nerve agents. JAMA 1989; 262: 649-63.
23. Koelle GB. Organophosphate poisoning - an overview Fundam Appl Toxic 1981; 1: 129-34
24. Lenz DE, Brimfield AA, Hunter KW, et al Studies using monoclonal antibodies against soman. Fundam Appl Toxicol 1984, 45; 5156-64.
25. Brimfield AA, Hunter KW, Lenz DE, et al: Structural and stereochemical specificity of mouse monoclonal antibodies to the organophosphorus cholinesterase inhibitor soman. Mol Pharmacol 1985; 28: 32-9.
26. Glikson M, Arad-Yellin R, Ghozi M, et al: Characterization of soma-binding antibodies raised against soma analogs. Mol Immunol 1992; 29: 903-10.
27. Lenz DE, Yourick JJ, Dawson JS, et al: Monoclonal antibodies against soman. characterization of soman stereoisomers. Immunol Lett 1992; 31: 131-6.
28. Bounafe AC, Rittenberg MB Combining site specificity of monoclonal antibodies to the organophosphate hapten soman. Mol Immunol 1987; 24: 401-7.
29. Buenafe AC, Makowski FF, Rittenberg MB: Molecular analysis and fine specificity of antibodies against an organophosphorus hapten. J Immunol 1989; 143: 539-45.
30. Dunn MA, Sidell FR: Progress in medical defense against nerve agents. JAMA 1989; 262: 649-53.
31. Sternberg LA, Sim VM, Kavanagh WG, et al: A vaccine against organophosphorus poisoning. Army Conference Proceedings 1972; 3: 429.
32. Rong KT, Zhang LJ: Immunologic protection against VS intoxication in experimental animals. Pharmacol Toxicol 1990, 67: 255-9.
33. Brimfield AA, Lenz DE: Progress in the production of catalytic antibodies as biological scavengers for organophosphorus poisons Proceedings of the 1991 Medical Defense Bioscience Review 1991; 12: 431-8
34. Wlodawer A, Miller M, Sjalin C: Active site RNAse neutron diffraction study of a complex with uridine vanadate transition state analog. Proc Natl Acad Sci USA 1983: 80. 3628-31.
35. Gentry MK, Saxena Y, et al. Immunochemical characterization of anti-acetylcholinesterase inhibitory monoclonal antibodies. Chem Biol Interact 1993; 87. 227-31.
36. Izadyar L, Friboulet A, Remy MH, et al: Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites, production of a catalytic antibody with a cholinesterase activity Proc Natl Acad Sci USA 1993, 90: 8876-80.